Evidence map›Paper›PMID 33532910›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

Improved in vivo PET imaging of the adenosine A

Thu Hang Lai, Magali Toussaint, Rodrigo Teodoro, Sladjana Dukić-Stefanović, Daniel Gündel, Friedrich-Alexander Ludwig, Barbara Wenzel, Susann Schröder, Bernhard Sattler, Rareş-Petru Moldovan and 4 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Development and evaluation of deuterated [EJNMMI radiopharmacy and chemistry · 2024
    Article
  2. Metabolic Stability of the Demyelination Positron Emission Tomography Tracer [The Journal of pharmacology and experimental therapeutics · 2023
    Article
  3. Article
  4. Quantitation of the APharmaceuticals (Basel, Switzerland) · 2022
    Article
  5. Pathophysiological Role and Medicinal Chemistry of AMolecules (Basel, Switzerland) · 2022
    Review
  6. Article
  7. ACurrent medicinal chemistry · 2022
    Review
  8. NRM 2021 Abstract Booklet.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  9. Development ofInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Thu Hang Lai *Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany. t.lai@hzdr.de.ORCID https://orcid.org/0000-0001-8157-8979
Magali Toussaint *Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany. m.toussaint@hzdr.de.ORCID https://orcid.org/0000-0002-1136-3857
Rodrigo TeodoroDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0002-1425-0567
Sladjana Dukić-StefanovićDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.
Daniel GündelDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0001-9743-2325
Friedrich-Alexander LudwigDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0002-4358-5171
Barbara WenzelDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0001-7390-3575
Susann SchröderDepartment of Research and Development, ROTOP Pharmaka Ltd., Dresden, Germany.ORCID https://orcid.org/0000-0001-6440-1362
Bernhard SattlerDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.ORCID https://orcid.org/0000-0003-3862-2609
Rareş-Petru MoldovanDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0003-3119-7945
Björn H FalkenburgerDepartment of Neurology, Dresden University Medical Center, Dresden, Germany.ORCID https://orcid.org/0000-0002-2387-526X
Osama SabriDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Winnie Deuther-Conrad *Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0003-3168-3062
Peter Brust *Department of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Leipzig, Germany.ORCID https://orcid.org/0000-0001-5555-7058
Helmholtz-Zentrum Dresden-Rossendorf · DEUniversity Hospital Leipzig · DETechnische Universität Dresden · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe adenosine A

methods[

results[

conclusionsThe new radiotracer [

Indexed as

Positron-Emission TomographyReceptor, Adenosine A2AAdenosineAnimalsBrainFluorine RadioisotopesMiceRadiopharmaceuticalsRatsSwineAdenosineFluorine RadioisotopesRadiopharmaceuticalsReceptor, Adenosine A2AA2A receptorAdenosine receptorsFESCHFluorine-18NeurodegenerationPositron-emission tomography

Identifiers

PMID33532910
PMCPMC8263428
OpenAlexW3126895124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.